Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor
Showing 1 - 25 of >10,000
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)
Active, not recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 10, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Healthy Volunteers Trial in Hannover (CSL324, Placebo)
Recruiting
- Healthy Volunteers
- CSL324
- Placebo
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023
Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)
Recruiting
- Granulocyte Colony-Stimulating Factor
- PD-1 Inhibitor
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Cervix Cancer, Endometrial Cancer Trial in Stanford (FDG PET/CT, GCSF)
Recruiting
- Cervix Cancer
- Endometrial Cancer
- FDG PET/CT
- GCSF
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Feb 11, 2022
Stem Cell Transplant Complications Trial in Edmonton (Loratadine, Placebo)
Not yet recruiting
- Stem Cell Transplant Complications
- Loratadine
- Placebo
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jun 13, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)
Not yet recruiting
- Leukemia, Acute Myeloid (AML)
- Clifutinib
- +5 more
- (no location specified)
Oct 16, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Postmenopausal Symptoms Trial in Aurora, Denver (G-CSF, Placebo/Saline)
Completed
- Postmenopausal Symptoms
- G-CSF
- Placebo/Saline
-
Aurora, Colorado
- +1 more
Apr 4, 2022
Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Granulocyte-Macrophage Colony-Stimulating Factor
- +4 more
-
Boston, MassachusettsTufts Medical Center
Oct 3, 2022
Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- BTK inhibitor
- PD-1 inhibitor
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Alzheimer, Mild Cognitive Impairment Trial in Cambridge, London, Oxford (JNJ-40346527, Placebo)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- JNJ-40346527
- Placebo
-
Cambridge, United Kingdom
- +2 more
Oct 27, 2020
Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)
Recruiting
- Neuroblastoma
- GM-CSF + Naxitamab
-
Gainesville, Florida
- +22 more
Aug 29, 2022